{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:39:23Z","timestamp":1792521563630,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670167"],"award-info":[{"award-number":["81670167"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Research Groups of the National Natural Science Foundation of China"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1038\/s41409-018-0410-3","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T11:05:17Z","timestamp":1548155117000},"page":"1319-1326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia"],"prefix":"10.1038","volume":"54","author":[{"given":"Zheng-Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Song","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"issue":"2","key":"410_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/bjh.13853","volume":"172","author":"Sally B. Killick","year":"2015","unstructured":"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2015. \n                    https:\/\/doi.org\/10.1111\/bjh.13853\n                    \n                  .","journal-title":"British Journal of Haematology"},{"key":"410_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1182\/blood-2007-08-099168","volume":"111","author":"Y Kosaka","year":"2008","unstructured":"Kosaka Y, Yagasaki H, Sano K, Kobayashi R, Ayukawa H, Kaneko T, et al. Prospective multicenter trial comparing repeated immunosuppressive therapy with stem-cell transplantation from an alternative donor as second-line treatment for children with severe and very severe aplastic anemia. Blood. 2008;111:1054\u20139. \n                    https:\/\/doi.org\/10.1182\/blood-2007-08-099168\n                    \n                  .","journal-title":"Blood"},{"key":"410_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","volume":"129","author":"A Bacigalupo","year":"2017","unstructured":"Bacigalupo A. How I treat acquired aplastic anemia. Blood. 2017;129:1428\u201336. \n                    https:\/\/doi.org\/10.1182\/blood-2016-08-693481\n                    \n                  .","journal-title":"Blood"},{"key":"410_CR4","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1182\/blood.V85.11.3058.bloodjournal85113058","volume":"85","author":"SJ Rosenfeld","year":"1995","unstructured":"Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood. 1995;85:3058\u201365.","journal-title":"Blood"},{"key":"410_CR5","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1182\/blood.V96.6.2049","volume":"96","author":"S Kojima","year":"2000","unstructured":"Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, et al. Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood. 2000;96:2049\u201354.","journal-title":"Blood"},{"key":"410_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s12185-016-2037-8","volume":"104","author":"A Bacigalupo","year":"2016","unstructured":"Bacigalupo A, Giammarco S, Sica S. Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia. Int J Hematol. 2016;104:168\u201374. \n                    https:\/\/doi.org\/10.1007\/s12185-016-2037-8\n                    \n                  .","journal-title":"Int J Hematol"},{"key":"410_CR7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","volume":"289","author":"S Rosenfeld","year":"2003","unstructured":"Rosenfeld S, Follmann D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003;289:1130\u20135.","journal-title":"JAMA"},{"key":"410_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1182\/blood-2011-12-274019","volume":"120","author":"P Scheinberg","year":"2012","unstructured":"Scheinberg P, Young NS. How I treat acquired aplastic anemia. Blood. 2012;120:1185\u201396. \n                    https:\/\/doi.org\/10.1182\/blood-2011-12-274019\n                    \n                  .","journal-title":"Blood"},{"key":"410_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1056\/NEJMoa1103975","volume":"365","author":"P Scheinberg","year":"2011","unstructured":"Scheinberg P, Nunez O, Weinstein B, Scheinberg P, Biancotto A, Wu CO, et al. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. N Eng J Med. 2011;365:430\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1103975\n                    \n                  .","journal-title":"N Eng J Med"},{"key":"410_CR10","doi-asserted-by":"publisher","first-page":"5391","DOI":"10.1182\/blood-2012-02-407684","volume":"119","author":"JC Marsh","year":"2012","unstructured":"Marsh JC, Bacigalupo A, Schrezenmeier H, Tichelli A, Risitano AM, Passweg JR, et al. Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party. Blood. 2012;119:5391\u20136. \n                    https:\/\/doi.org\/10.1182\/blood-2012-02-407684\n                    \n                  .","journal-title":"Blood"},{"key":"410_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00277-004-0930-3","volume":"84","author":"R Viollier","year":"2005","unstructured":"Viollier R, Passweg J, Gregor M, Favre G, Kuhne T, Nissen C, et al. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia. Ann Hematol. 2005;84:47\u201355. \n                    https:\/\/doi.org\/10.1007\/s00277-004-0930-3\n                    \n                  .","journal-title":"Ann Hematol"},{"key":"410_CR12","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/bmt.2012.79","volume":"47","author":"LP Xu","year":"2012","unstructured":"Xu LP, Liu KY, Liu DH, Han W, Chen H, Chen YH, et al. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia. Bone Marrow Transplant. 2012;47:1507\u201312. \n                    https:\/\/doi.org\/10.1038\/bmt.2012.79\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"410_CR13","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbmt.2013.01.023","volume":"19","author":"HJ Im","year":"2013","unstructured":"Im HJ, Koh KN, Choi ES, Jang S, Kwon SW, Park CJ, et al. Excellent outcome of haploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemia. Biol Blood Marrow Transplant. 2013;19:754\u20139. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2013.01.023\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"},{"key":"410_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/bmt.2013.224","volume":"49","author":"L Gao","year":"2014","unstructured":"Gao L, Li Y, Zhang Y, Chen X, Gao L, Zhang C, et al. Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy. Bone Marrow Transplant. 2014;49:519\u201324. \n                    https:\/\/doi.org\/10.1038\/bmt.2013.224\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"410_CR15","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.bbmt.2014.06.028","volume":"20","author":"J Clay","year":"2014","unstructured":"Clay J, Kulasekararaj AG, Potter V, Grimaldi F, McLornan D, Raj K, et al. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Biol Blood Marrow Transplant. 2014;20:1711\u20136. \n                    https:\/\/doi.org\/10.1016\/j.bbmt.2014.06.028\n                    \n                  .","journal-title":"Biol Blood Marrow Transplant"},{"key":"410_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/bmt.2015.20","volume":"50","author":"I Esteves","year":"2015","unstructured":"Esteves I, Bonfim C, Pasquini R, Funke V, Pereira NF, Rocha V, et al. Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplant. 2015;50:685\u20139. \n                    https:\/\/doi.org\/10.1038\/bmt.2015.20\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"410_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/bjh.14225","volume":"175","author":"Lan-Ping Xu","year":"2016","unstructured":"Xu LP, Wang SQ, Wu DP, Wang JM, Gao SJ, Jiang M et al. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study. Br J Haematol. 2016. \n                    https:\/\/doi.org\/10.1111\/bjh.14225\n                    \n                  .","journal-title":"British Journal of Haematology"},{"key":"410_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-017-0398-y","volume":"10","author":"LP Xu","year":"2017","unstructured":"Xu LP, Jin S, Wang SQ, Xia LH, Bai H, Gao SJ, et al. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant. J Hematol Oncol. 2017;10:25 \n                    https:\/\/doi.org\/10.1186\/s13045-017-0398-y\n                    \n                  .","journal-title":"J Hematol Oncol"},{"key":"410_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2141.1988.tb02460.x","volume":"70","author":"A Bacigalupo","year":"1988","unstructured":"Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol. 1988;70:177\u201382.","journal-title":"Br J Haematol"},{"key":"410_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bjh.13614","volume":"171","author":"C Dufour","year":"2015","unstructured":"Dufour C, Veys P, Carraro E, Bhatnagar N, Pillon M, Wynn R, et al. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT. Br J Haematol. 2015;171:585\u201394. \n                    https:\/\/doi.org\/10.1111\/bjh.13614\n                    \n                  .","journal-title":"Br J Haematol"},{"key":"410_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/bjh.14097","volume":"177","author":"J Mackarel","year":"2017","unstructured":"Mackarel J, Iatan M, Kumar L, Storey L, O\u2019Marcaigh A, Smith O. In support of upfront stem cell transplantation as first-line therapy for paediatric patients with idiopathic severe aplastic anaemia who lack a sibling donor. Br J Haematol. 2017;177:806\u20138. \n                    https:\/\/doi.org\/10.1111\/bjh.14097\n                    \n                  .","journal-title":"Br J Haematol"},{"key":"410_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/bmt.2016.223","volume":"52","author":"YB Choi","year":"2017","unstructured":"Choi YB, Yi ES, Lee JW, Sung KW, Koo HH, Yoo KH. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor. Bone Marrow Transplant. 2017;52:47\u201352. \n                    https:\/\/doi.org\/10.1038\/bmt.2016.223\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"410_CR23","doi-asserted-by":"publisher","first-page":"e13179","DOI":"10.1111\/ctr.13179","volume":"32","author":"Yifei Cheng","year":"2018","unstructured":"Cheng Y, Xu Z, Zhang Y, Wu J, Wang F, Mo X. First-line choice for severe aplastic anemia in children: Transplantation from a haploidentical donor vs immunosuppressive therapy. Clin Transplant. 2018;32. \n                    https:\/\/doi.org\/10.1111\/ctr.13179\n                    \n                  .","journal-title":"Clinical Transplantation"},{"key":"410_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/bmt.2016.140","volume":"51","author":"SE Lee","year":"2016","unstructured":"Lee SE, Yahng SA, Cho BS, Eom KS, Kim YJ, Kim HJ, et al. Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia. Bone Marrow Transplant. 2016;51:1323\u20139. \n                    https:\/\/doi.org\/10.1038\/bmt.2016.140\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"410_CR25","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1182\/blood-2003-07-2546","volume":"103","author":"L Ades","year":"2004","unstructured":"Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004;103:2490\u20137. \n                    https:\/\/doi.org\/10.1182\/blood-2003-07-2546\n                    \n                  .","journal-title":"Blood"},{"key":"410_CR26","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","volume":"376","author":"DM Townsley","year":"2017","unstructured":"Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, et al. Eltrombopag added to standard immunosuppression for aplastic anemia. N Eng J Med. 2017;376:1540\u201350. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1613878\n                    \n                  .","journal-title":"N Eng J Med"},{"key":"410_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood.V73.2.606.606","volume":"73","author":"RE Champlin","year":"1989","unstructured":"Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood. 1989;73:606\u201313.","journal-title":"Blood"},{"key":"410_CR28","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"410_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204\u201317.","journal-title":"Am J Med"},{"key":"410_CR30","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/bmt.2017.237","volume":"53","author":"LP Xu","year":"2018","unstructured":"Xu LP, Xu ZL, Wang FR, Mo XD, Han TT, Han W, et al. Unmanipulated haploidentical transplantation conditioning with busulfan, cyclophosphamide and anti-thymoglobulin for adult severe aplastic anaemia. Bone Marrow Transplant. 2018;53:188\u201392. \n                    https:\/\/doi.org\/10.1038\/bmt.2017.237\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"key":"410_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000445820","volume":"136","author":"H Kim","year":"2016","unstructured":"Kim H, Lee JH, Joo YD, Bae SH, Lee SM, Jo JC, et al. Comparable allogeneic hematopoietic cell transplantation outcome of a haplo-identical family donor with an alternative donor in adult aplastic anemia. Acta haematol. 2016;136:129\u201339. \n                    https:\/\/doi.org\/10.1159\/000445820\n                    \n                  .","journal-title":"matol"},{"key":"410_CR32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/bmt.2014.187","volume":"49","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zheng X, Yan H, Li D, Wang H. Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia. Bone Marrow Transplant. 2014;49:1481\u20135. \n                    https:\/\/doi.org\/10.1038\/bmt.2014.187\n                    \n                  .","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"410_CR33","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","volume":"124","author":"Yu Wang","year":"2014","unstructured":"Wang Y, Chang YJ, Xu LP, Liu KY, Liu DH, Zhang XH. et al. Who is the best donor for a related HLA haplotype-mismatched transplant?. Blood. 2014. \n                    https:\/\/doi.org\/10.1182\/blood-2014-03-563130\n                    \n                  .","journal-title":"Blood"},{"key":"410_CR34","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.3324\/haematol.2014.109355","volume":"99","author":"N Yoshida","year":"2014","unstructured":"Yoshida N, Kobayashi R, Yabe H, Kosaka Y, Yagasaki H, Watanabe K, et al. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy. Haematologica. 2014;99:1784\u201391. \n                    https:\/\/doi.org\/10.3324\/haematol.2014.109355\n                    \n                  .","journal-title":"Haematologica"},{"key":"410_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0037-1963(00)90031-3","volume":"37","author":"A Bacigalupo","year":"2000","unstructured":"Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J, et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. Semin Hematol. 2000;37:69\u201380.","journal-title":"Semin Hematol"},{"key":"410_CR36","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.3324\/haematol.2010.026682","volume":"95","author":"V Gupta","year":"2010","unstructured":"Gupta V, Eapen M, Brazauskas R, Carreras J, Aljurf M, Gale RP, et al. Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors. Haematologica. 2010;95:2119\u201325. \n                    https:\/\/doi.org\/10.3324\/haematol.2010.026682\n                    \n                  .","journal-title":"Haematologica"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0410-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0410-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:13:41Z","timestamp":1684602821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0410-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0410-3","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]},"assertion":[{"value":"13 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}